BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Regen BioPharma  

4700 Spring Street
Suite 304
La Mesa  California  91942  U.S.A.
Phone: 619-702-1404 Fax: 619-330-2328


SEARCH JOBS










 Company News
Regen BioPharma Provides Update On dCellVax Breast Cancer Immunotherapy 8/5/2014 10:50:45 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB) Subsidiary Regen BioPharma Collaborates On Research Paper Analyzing The Use Of Gene Silencing In Heart Transplants 6/12/2014 10:17:07 AM
Regen BioPharma , A Majority Owned Subsidiary Of Bio-Management, Provides Update On Hemaxellerate I™ IND For Treatment Of Drug Resistant Aplastic Anemia 5/13/2014 10:05:10 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB) Announces Dividend Record Date To Receive Shares In Its Subsidiary Regen BioPharma 3/7/2014 9:42:10 AM
Regen BioPharma Announces HemaXellerate I™ Efficacy Data In Animal Model Of Aplastic Anemia 12/11/2013 10:29:40 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB) Announces 20 Million Share Regen BioPharma Dividend to be Paid to Shareholders 10/10/2013 8:47:32 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Subsidiary Regen BioPharma Enters Into Preclinical Trials Agreement for HemaXellerate I Covering Aplastic Anemia 9/26/2013 9:30:20 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Subsidiary, Regen BioPharma Announces dCellVax Breast Cancer Immunotherapeutic Product 9/25/2013 9:13:36 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB) Recruits RNA Interference Pioneer Dr. David Suhy to Regen BioPharma Scientific Advisory Board 9/17/2013 10:38:45 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB) Discusses Regen BioPharma 's Cancer Immunotherapy Program 8/19/2013 9:19:34 AM
12